Cargando…

应用聚乙二醇化重组人G-CSF预防淋巴瘤患者化疗后中性粒细胞减少:一项前瞻、多中心、开放性临床研究

OBJECTIVE: To evaluate the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in prophylaxis neutropenia after chemotherapy in patients with lymphoma. METHODS: This was a multicenter, single arm, open, phase Ⅳ clinical trial. Included 410 patients...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364967/
https://www.ncbi.nlm.nih.gov/pubmed/29166732
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.001